In the run-up to tomorrow's Capital Markets Day, CEO of Finnish Stora Enso Karl-Henrik Sundström announced that the Group's investment volume for 2019 would be at the level of its forecast annual depreciation.. In 2019, the estimated capital expenditure will be EUR 550–600 million, including EUR 100 million for biological assets.  The forecasted annual depreciation is EUR 490–510 million and operational decrease in the value of biological assets EUR 50–70 million. Capital expenditure amounts do not include potential acquisitions or divestments and are excluding the impact of IFRS 16 Leases ...